Lidocaine HCl / Oxymetazoline HCl Nasal Solution Recalled for CGMP Deviations
Edge Pharma, LLC is recalling Lidocaine HCl / Oxymetazoline HCl Nasal Solution (4% / 0.05%, 240mL) nationwide due to Current Good Manufacturing Practice (CGMP) deviations.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall for CGMP deviations without reported illnesses or injuries. The source text does not mention any adverse health events, hospitalization, or safety incidents—only manufacturing practice violations. Under the rubric, Class II recalls without reported harm are typically Moderate.
Plain-English summary
Edge Pharma, LLC is recalling Lidocaine HCl / Oxymetazoline HCl Nasal Solution, 4% / 0.05%, 240mL per bottle, packaged in multiple-dose containers for intranasal use. The product is identified by NDC 05446-1256-01. Approximately 386 bottles have been distributed nationwide.
The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations. This is a voluntary recall initiated by the firm. The FDA classified this recall as Class II.
Consumers who have this product should not use it. Patients and healthcare providers with questions should contact Edge Pharma, LLC at 856 Hercules Dr., Colchester, VT 05446, or refer to the FDA's drug recalls page for more information.
The recalled product
- Product
- Lidocaine HCl / Oxymetazoline HCl Nasal Solution, 4% / 0.05%, 240mL per bottle, Multiple Dose Container for Intranasal Use, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1256-01, packaged in bottles. no label
- Manufacturer
- Edge Pharma, LLC
- Category
- Drug — Nasal Solution / Topical
- Affected units
- 386
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 56 recalled by Edge Pharma, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 56 products in this recall →Related recalls
Same manufacturer · Edge Pharma, LLC
See all →- ModerateProfound-PE Dental Gel Recalled for Manufacturing Deviations
FDA (Drugs) · 2022-02-02
- SevereMVASI Sterile Ophthalmic Solution Lacks Assured Sterility
FDA (Drugs) · 2022-02-02
- ModerateLET Topical Gel drug recall for CGMP deviations
FDA (Drugs) · 2022-02-02
- SevereVancomycin HCl Injection Recalled for Sterility Assurance Issues
FDA (Drugs) · 2022-02-02
- ModerateCSF-HC Otic Powder Drug Recalled for Manufacturing Deviations
FDA (Drugs) · 2022-02-02
Same hazard · manufacturing deviations
See all →- ModeratePain & Sinus Reliever tablets recalled for manufacturing deviations
FDA (Drugs) · 2022-02-09